LON:EMIS EMIS Group (EMIS) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About EMIS Group Stock (LON:EMIS) Get EMIS Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume433,828 shsAverage Volume675,394 shsMarket Capitalization£1.23 billionP/E Ratio4,085.11Dividend Yield2.21%Price TargetN/AConsensus RatingN/A Company Overview EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited. Read More Receive EMIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMIS Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EMIS Stock News HeadlinesTrapped by EMIs, woman earning ₹12 LPA works 12-hour days, cries every nightNovember 11, 2025 | msn.comBlackstone among suitors for UnitedHealth-owned Optum UKOctober 24, 2025 | msn.comSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing total outflows to 14 billion. At the same time, the World Gold Council recorded the highest quarterly central bank gold buying on record, with buyers taking physical delivery instead of paper shares. | Behind the Markets (Ad)‘Crushed By EMIs And Inflation’: Bengaluru CEO Warns Of Middle-Class SqueezeMay 22, 2025 | msn.com'Inflation, EMIs, Quiet Pressure': Bengaluru CEO’s 'Save Middle Class' Post Is TrendingMay 22, 2025 | msn.comIndia's middle class is bleeding quietly: Bengaluru CEO says, 'EMIs, inflation, no savings are crushing them'May 22, 2025 | msn.comRand Paul wants to bring back Trump's 'Remain in Mexico' policy as a Senate chairNovember 14, 2024 | msn.comUS Treasury finds no currency manipulation by major trading partnersNovember 14, 2024 | msn.comSee More Headlines EMIS Stock Analysis - Frequently Asked Questions How were EMIS Group's earnings last quarter? EMIS Group plc (LON:EMIS) posted its earnings results on Wednesday, March, 14th. The company reported $47.20 earnings per share for the quarter, beating the consensus estimate of $46.30 by $0.90. The company had revenue of $160.35 million for the quarter. EMIS Group had a trailing twelve-month return on equity of 23.17% and a net margin of 17.23%. How do I buy shares of EMIS Group? Shares of EMIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of EMIS Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that EMIS Group investors own include RM (RM), Babcock International Group (BAB), The Character Group (CCT), BP (BP), Tullow Oil (TLW) and Vodafone Group Public (VOD). Company Calendar Last Earnings3/14/2018Today8/23/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolLON:EMIS CIKN/A Webwww.emisgroupplc.com Phone+44-113-3803000FaxN/AEmployees1,560Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.47 Trailing P/E Ratio4,085.11 Forward P/E RatioN/A P/E Growth1.37Net Income£30.48 million Net Margins17.23% Pretax MarginN/A Return on Equity23.17% Return on Assets7.99% Debt Debt-to-Equity Ratio2.96 Current Ratio1.07 Quick Ratio1.83 Sales & Book Value Annual Sales£176.86 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow21.90 Book ValueGBX 210 per share Price / BookN/AMiscellaneous Outstanding Shares64,160,000Free FloatN/AMarket Cap£1.23 billion OptionableNot Optionable Beta-0.13 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (LON:EMIS) was last updated on 8/24/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredBank of America grew this stake 139%Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredFree Stock Pick: The Company First in Line for America’s New Super FuelThe U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...Banyan Hill Publishing | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredThe Musk-linked sector everyone's sleeping onMicron, a key Musk supplier, surged 1,121% in under two years after Jeff Brown flagged it early. Now Brown ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMIS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EMIS Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.